* Meta-terms correspond to biological or medical specialty concerned
with one or more keywords (or keywords hierarchies), qualifiers, or resource types.
Other terms also benefit from this structure, when the topic warrants it, eg education.
See the list.
Preferred Label : drugs;
True Meta (CISMeF) : O;
Origin ID : MT126;
ATC codes
Automatic exact mappings (from CISMeF team)
- Drug [ICD-11 Extension code]
- Drug [ICHI extension code]
- Drugs [ICHI extension code]
- drug [Blood Transfusion thesaurus concept]
- drug [Artificial nutrition thesaurus concept]
CISMeF Querying Strategi(ies)
CISMeF Resource Types
CISMeF manual mappings
Currated CISMeF NLP mapping
MeSH
MeSH qualifiers
SNOMED CT concepts
SNOMED int. notions
See also
Semantic type(s)
https://ansm.sante.fr/tableau-marr/icodextrine
2025
false
false
false
France
French
risk management
guidelines for drug use
peritoneal dialysis
blood glucose self-monitoring
Icodextrin
Blood glucose meter (physical object)
directory
patient education handout
---
https://ansm.sante.fr/tableau-marr/levodopa-carbidopa
2025
false
false
false
France
French
risk management
carbidopa
levodopa
drug combinations
carbidopa, levodopa drug combination
Intestinal Route of Administration
patient care
nursing care
patient care planning
guidelines for drug use
patient education handout
continuity of patient care
patient care management
---
https://ansm.sante.fr/tableau-acces-derogatoire/opdivo-nivolumab-solution-a-diluer-pour-perfusion-yervoy-ipilimumab-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
guidelines for drug use
Nivolumab
Ipilimumab/Nivolumab Regimen
Ipilimumab
Antineoplastic Agents, Immunological
Malignant Pleural Mesothelioma
disease progression
Progressive Neoplastic Disease
infusions, intravenous
continuity of patient care
drug monitoring
carcinoma, non-small-cell lung
melanoma
Stage IIB Cutaneous Melanoma AJCC v6 and v7
Stage IIIB Cutaneous Melanoma AJCC v7
technical report
---
https://ansm.sante.fr/tableau-marr/tolvaptan
2025
false
false
false
France
French
risk management
Tolvaptan
Tolvaptan
administration, oral
tolvaptan
polycystic kidney, autosomal dominant
continuity of patient care
liver diseases
pregnancy
guidelines for drug use
patients guideline
patient education handout
---
https://ansm.sante.fr/tableau-marr/alpelisib
2025
false
false
false
France
French
guidelines for drug use
administration, oral
Drug-Related side effects and adverse reactions
alpelisib
Alpelisib
Alpelisib
continuity of patient care
Hyperglycaemic hyperosmolar nonketotic syndrome
hyperglycemia
ketosis
thiazoles
thiazoles
---
https://ansm.sante.fr/tableau-marr/esketamine
2025
false
false
false
France
French
guidelines for drug use
patients guideline
patient education handout
Esketamine
ketamine
dissociative disorders
administration, intranasal
antidepressive agents
risk management
esketamine
Esketamine
antidepressive agents
continuity of patient care
dissociation
Sleepiness
hypertension
Drug Misuse
ketamine
---
https://ansm.sante.fr/tableau-marr/fingolimod
2025
false
false
false
France
French
guidelines for drug use
patient education handout
Fingolimod Hydrochloride
pregnancy
administration, oral
immunosuppressive agents
immunosuppressive agents
fingolimod
continuity of patient care
Fingolimod Hydrochloride
teratogens
multiple sclerosis, relapsing-remitting
breast feeding
Fingolimod Hydrochloride
risk management
---
https://ansm.sante.fr/tableau-marr/olanzapine
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Olanzapine
risk management
olanzapine
injections, intramuscular
Delayed-Action preparations
Olanzapine
metabolic diseases
continuity of patient care
drug compounding
injections, intramuscular
olanzapine pamoate
olanzapine pamoate
schizophrenia
antipsychotic agents
antipsychotic agents
medication errors
Post-injection delirium sedation syndrome (finding)
---
https://ansm.sante.fr/tableau-acces-derogatoire/selpercatinib-20-40-et-80mg-gelule
2025
false
false
false
France
French
selpercatinib
administration, oral
carcinoma, non-small-cell lung
advanced RET fusion-positive non-small cell lung cancer
Product containing only selpercatinib in oral dose form (medicinal product form)
thyroid cancer, medullary
drug information
selpercatinib
pyrazoles
pyridines
---
https://ansm.sante.fr/tableau-atu-rtu/abecma-260-500-x-106-cellules-dispersion-pour-perfusion
2025
false
false
false
France
French
guidelines for drug use
Idecabtagene Vicleucel
Idecabtagene Vicleucel
gene therapy
immunotherapy, adoptive
adult
multiple myeloma
recurrence
Refractory Multiple Myeloma
idecabtagene vicleucel
idecabtagene vicleucel
Recurrent Multiple Myeloma
genetic therapy
---
https://ansm.sante.fr/tableau-marr/fenfluramine
2025
false
false
false
France
French
administration, oral
risk management
guidelines for drug use
pharmacovigilance note
fenfluramine
fenfluramine
continuity of patient care
drug monitoring
hypertension, pulmonary
Drug-Related side effects and adverse reactions
heart valve diseases
patients guideline
Off-Label use
---
https://ansm.sante.fr/tableau-marr/fentanyl-3
2025
false
false
false
France
French
fentanyl
analgesics, opioid
risk management
narcotics
guidelines for drug use
patients guideline
administration, intranasal
nasal sprays
fentanyl
patient education handout
---
https://ansm.sante.fr/tableau-marr/fentanyl-4
2025
false
false
false
France
French
fentanyl
risk management
narcotics
analgesics, opioid
guidelines for drug use
patients guideline
administration, buccal
Orally Disintegrating Film Dosage Form
fentanyl
---
https://ansm.sante.fr/tableau-marr/fentanyl-5
2025
false
false
false
France
French
administration, sublingual
fentanyl
analgesics, opioid
risk management
narcotics
guidelines for drug use
patients guideline
fentanyl
Sublingual Tablet Dosage Form
---
https://ansm.sante.fr/tableau-acces-derogatoire/slenyto
2025
false
false
false
France
French
guidelines for drug use
melatonin
administration, oral
Delayed-Action preparations
child
adolescent
sleep disorders, circadian rhythm
melatonin
rett syndrome
angelman syndrome
tuberous sclerosis
technical report
---
https://ansm.sante.fr/tableau-acces-derogatoire/arikayce-liposomal
2025
false
false
false
France
French
guidelines for drug use
mycobacterium infections, nontuberculous
amikacin
liposomes
administration, inhalation
pneumonia, bacterial
anti-bacterial agents
Mycobacterium abscessus
amikacin
Infection caused by Mycobacteroides abscessus (disorder)
---
https://ansm.sante.fr/tableau-acces-derogatoire/venclyxto-10-mg-50mg-100-mg-comprimes-pellicules?#
2025
false
false
false
France
French
venetoclax
venetoclax
Recurrent Acute Myeloid Leukemia
Refractory Acute Myeloid Leukemia
leukemia, myeloid, acute
precursor cell lymphoblastic Leukemia-Lymphoma
Refractory Acute Lymphoblastic Leukemia
Recurrent Acute Lymphoblastic Leukemia
leukemia, lymphocytic, chronic, B-Cell
drug information
Product containing only venetoclax in oral dose form (medicinal product form)
guidelines for drug use
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
---
https://publications.msss.gouv.qc.ca/msss/document-002783/
2025
false
false
false
Canada
popular works
vaccinia virus vaccine
vaccination
Vaccins
Vaccinia
vaccinia
vaccines
preventive immunization/medication
vaccination
vaccinia
---
https://www.inesss.qc.ca/covid-19/autres-traitements/utilisation-des-antiviraux-pour-le-traitement-et-la-prophylaxie-de-linfluenza-chez-lenfant-et-ladulte-dans-le-contexte-de-la-covid-19.html
2025
false
false
false
Canada
coronavirus infections
pneumonia, viral
influenza, human
aged
influenza, human
risk factors
oseltamivir
zanamivir
continuity of patient care
practice guideline
guidelines for drug use
influenza, human
child
antiviral agents
adult
pandemics
COVID-19
---
https://ansm.sante.fr/dossiers-thematiques/cannabis-a-usage-medical
2025
false
false
false
false
France
medical marijuana
drug information
medical marijuana
---
https://publications.msss.gouv.qc.ca/msss/document-001617/
2025
false
false
false
Canada
pneumonia, viral
coronavirus infections
scientific and technical information
Population Forecast
Respect
population
coronavirus, nos
projection
coronavirus
appraiser
homing behavior
projection
population
projection
pandemics
COVID-19
---
https://ansm.sante.fr/tableau-marr/rivastigmine
2025
false
false
false
France
French
guidelines for drug use
patients guideline
risk management
Rivastigmine
rivastigmine
transdermal patch
administration, cutaneous
drug overdose
prescription drug misuse
medication errors
---
http://publications.msss.gouv.qc.ca/msss/document-001040/
2025
false
true
false
Canada
immunization schedule
vaccines
measles-mumps-rubella vaccine
meningococcal vaccines
pneumococcal vaccines
influenza vaccines
Diphtheria-Tetanus-Pertussis vaccine
rotavirus vaccines
child
infant
popular works
vaccination
---
https://ansm.sante.fr/tableau-acces-derogatoire/ospolot#
2025
false
false
false
France
French
guidelines for drug use
administration, oral
sulthiame
anticonvulsants
Developmental and epileptic encephalopathy with spike-wave activation in sleep
continuity of patient care
sultiame
child
adolescent
adult
ospolot
epilepsy, rolandic
landau-kleffner syndrome
technical report
Product containing only sulthiamine (medicinal product)
thiazines
---
https://ansm.sante.fr/tableau-acces-derogatoire/sirdalud
2025
false
false
false
France
French
summary of product characteristics
Product containing precisely tizanidine (as tizanidine hydrochloride) 4 milligram/1
each conventional release oral tablet (clinical drug)
tizanidine
muscle spasticity
drug information
clonidine
clonidine
---
Optimal long-term use of proton pump inhibitors
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/usage-optimal-a-long-terme-des-inhibiteurs-de-la-pompe-a-protons.html
2025
false
false
false
Canada
French
English
proton pump inhibitors
guidelines for drug use
Long-term drug therapy (procedure)
insurance, health, reimbursement
drug prescriptions
time
quebec
---
http://www.has-sante.fr/jcms/c_2655426/fr/referentiel-de-certification-de-l-activite-d-information-par-demarchage-ou-prospection-visant-a-la-promotion-des-medicaments
2025
false
false
false
France
French
technical report
certification
promoter regions, genetic
orphan drug, nos
pharmaceutical preparations
---
https://ansm.sante.fr/documents/reference/medicaments-biosimilaires
2025
false
false
false
France
French
drug information
biosimilar pharmaceuticals
directory
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/allergie-aux-penicillines.html
2025
false
false
false
false
France
French
algorithms
scientific and technical information
penicillins
drug hypersensitivity
decision making
Allergy to penicillin (finding)
---
https://ansm.sante.fr/tableau-marr/teriflunomide
2025
false
false
false
France
French
administration, oral
risk reduction
patients guideline
handbooks
pregnancy
teratogens
teriflunomide
risk management
contraception
Contraindications, Drug
breast feeding
Chemical and Drug Induced Liver Injury
continuity of patient care
multiple sclerosis, relapsing-remitting
leukopenia
hypertension
opportunistic infections
teriflunomide
crotonates
toluidines
crotonates
toluidines
---
https://ansm.sante.fr/tableau-marr/clozapine
2025
false
false
false
France
French
clozapine
risk management
patient education handout
blood cell count
forms
agranulocytosis
continuity of patient care
drug monitoring
---
https://ansm.sante.fr/tableau-marr/hydroxycarbamide
2025
false
false
false
France
French
teratogens
hydroxyurea
hydroxyurea
continuity of patient care
guidelines for drug use
risk management
anemia, sickle cell
pain
adult
child
adolescent
fertility
pregnancy
contraception
blood cell count
hematologic diseases
patients guideline
---
https://ansm.sante.fr/tableau-marr/lutecium-177lu-oxodotreotide
2025
false
false
false
France
French
lutetium Lu 177 dotatate
risk management
patients guideline
lutetium Lu 177 dotatate
infusions, intravenous
radiotherapy
radiopharmaceuticals
radiopharmaceuticals
neuroendocrine tumors
lutetium (177Lu) oxodotreotide
drug information
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide
---
https://ansm.sante.fr/tableau-marr/mycophenolate-mofetil
2025
false
false
false
France
French
teratogens
contraception
pregnancy
mycophenolate mofetil
abnormalities, drug-induced
abortion, spontaneous
mycophenolic acid
patient education handout
handbooks
mycophenolic acid
---
https://ansm.sante.fr/tableau-marr/pomalidomide
2025
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide
---
https://ansm.sante.fr/tableau-acces-derogatoire/dabrafenib
2025
false
false
false
France
French
dabrafenib
drug information
guidelines for drug use
administration, oral
summary of product characteristics
package leaflet
Disintegrating Tablet Dosage Form
glioma
dabrafenib
child
BRAF Inhibitor
infant
---
https://ansm.sante.fr/tableau-acces-derogatoire/trametinib
2025
false
false
false
France
French
summary of product characteristics
package leaflet
administration, oral
Powder for Oral Solution Dosage Form
child
guidelines for drug use
trametinib
trametinib
drug information
glioma
BRAF Inhibitor
---
https://ansm.sante.fr/tableau-marr/glofitamab
2025
false
false
false
France
French
guidelines for drug use
risk management
antibodies, bispecific
antibodies, bispecific
glofitamab
glofitamab
patients guideline
Tumor Flare Reaction
signs and symptoms
continuity of patient care
Cytokine Release Syndrome
glofitamab
---
https://ansm.sante.fr/tableau-marr/lisocabtagene-maraleucel
2025
false
false
false
France
French
guidelines for drug use
risk management
Lisocabtagene Maraleucel
Lisocabtagene Maraleucel
Product containing only lisocabtagene maraleucel in parenteral dose form (medicinal
product form)
Cytokine Release Syndrome
continuity of patient care
gene therapy
immunotherapy, adoptive
signs and symptoms
nervous system diseases
patients guideline
lisocabtagene maraleucel
---
https://ansm.sante.fr/tableau-marr/lomitapide
2025
false
false
false
France
French
risk management
lomitapide
lomitapide
patient education handout
guideline
drug interactions
anticholesteremic agents
lomitapide
anticholesteremic agents
administration, oral
---
https://ansm.sante.fr/informations-de-securite/arret-de-commercialisation-de-soludactone-recommandations-de-lansm
2025
false
false
false
France
French
drug information
drug combinations
canrenoic acid
canrenoate potassium
aldosterone antagonists
diuretics
tromethamine
hypokalemia
---
https://ansm.sante.fr/tableau-acces-derogatoire/methotrexate
2025
false
false
false
France
French
methotrexate
guidelines for drug use
pregnancy, ectopic
administration, oral
pharmaceutical solutions
injections
arthritis, juvenile
uveitis, anterior
drug information
precursor cell lymphoblastic Leukemia-Lymphoma
---
https://publications.msss.gouv.qc.ca/msss/document-001509/
2025
false
false
false
Canada
patient education handout
Vaccinia
vaccination
vaccines
preventive immunization/medication
vaccinia virus vaccine
Vaccins
students
vaccination
---
https://ansm.sante.fr/tableau-acces-derogatoire/alpelisib-200-mg-comprimes-pellicules
2025
false
false
false
France
French
Alpelisib
administration, oral
drug information
guidelines for drug use
congenital lipomatous overgrowth, vascular malformations, and epidermal nevi
PIK3CA-related overgrowth syndrome
PIK3CA-Related Overgrowth Spectrum
Phosphatidylinositide 3-Kinase Inhibitor
summary of product characteristics
technical report
---
https://ansm.sante.fr/tableau-acces-derogatoire/rybrevant
2025
false
false
false
France
French
summary of product characteristics
amivantamab
Antineoplastic Agents, Immunological
amivantamab
advanced non-small cell lung cancer with activating epidermal growth factor receptor
exon 20 insertion mutations
carcinoma, non-small-cell lung
guidelines for drug use
package leaflet
EGFR Exon 19 Deletion Mutation
EGFR NP_005219.2:p.L858R
EGFR Exon 20 Insertion Mutation
---
https://ansm.sante.fr/tableau-acces-derogatoire/epcoritamab
2025
false
true
false
France
French
drug information
lymphoma, large B-Cell, diffuse
Epcoritamab
epcoritamab
technical report
injections, subcutaneous
Antineoplastic Agents, Immunological
bispecific monoclonal antibodies
Refractory Diffuse Large B-Cell Lymphoma
Recurrent Diffuse Large B-Cell Lymphoma
---
https://ansm.sante.fr/tableau-marr/eliglustat
2025
false
false
false
France
French
risk management
eliglustat
guidelines for drug use
drug interactions
popular works
eliglustat
gaucher disease, type 1
Cytochrome P-450 CYP2D6 Inhibitors
P-glycoprotein Inhibitor
Genotyping
continuity of patient care
Metabolic Side Effects of Drugs and Substances
---
https://ansm.sante.fr/tableau-acces-derogatoire/elranatamab
2025
false
false
false
France
French
Elranatamab
multiple myeloma
adult
Relapsed/refractory multiple myeloma
Recurrent Multiple Myeloma
Triple-Class Refractory Multiple Myeloma
antibodies, monoclonal
drug information
elranatamab
---
https://ansm.sante.fr/tableau-marr/fentanyl-8
2025
false
false
false
France
French
fentanyl
patients guideline
guidelines for drug use
risk management
video recording
guideline
fentanyl
---
https://www.has-sante.fr/jcms/p_3431851/fr/xenpozyme-olipudase-alfa-deficit-en-sphingomyelinase-acide
2025
false
false
false
France
evaluation of the transparency committee
sphingomyelin/cholesterol lipidosis, nos
xenpozyme
acid, nos
olipudase alfa
niemann-pick diseases
olipudase alfa
---
https://ansm.sante.fr/tableau-acces-derogatoire/maribavir
2025
false
false
false
France
French
maribavir
drug information
administration, oral
maribavir
cytomegalovirus infections
adult
Refractory Cytomegalovirus Infection
antiviral agents
---
https://ansm.sante.fr/tableau-marr/adrenaline
2025
false
false
false
France
French
risk management
guidelines for drug use
epinephrine
epinephrine
Self injection
self administration
patient education handout
video recording
---
https://ansm.sante.fr/tableau-acces-derogatoire/jakavi-5-mg-comprime
2025
false
false
false
France
French
insurance, health, reimbursement
ruxolitinib phosphate
ruxolitinib
administration, oral
graft vs host disease
Steroid Refractory Graft Versus Host Disease
acute disease
chronic disease
pharmaceutical solutions
child
guidelines for drug use
summary of product characteristics
package leaflet
tablets
---
https://ansm.sante.fr/tableau-marr/upadacitinib
2025
false
false
false
France
French
risk management
upadacitinib
patient education handout
guidelines for drug use
upadacitinib
Drug-Related side effects and adverse reactions
administration, oral
upadacitinib
Janus Kinase Inhibitors
Janus Kinase Inhibitors
teratogens
pregnancy
continuity of patient care
herpes zoster
tuberculosis
neoplasms
embolism and thrombosis
Virus Reactivation
---
https://ansm.sante.fr/tableau-acces-derogatoire/zilucoplan#
2025
false
false
false
France
French
drug information
injections, subcutaneous
zilucoplan
generalised myasthenia gravis with anti-acetylcholine receptor antibody
adult
myasthenia gravis, generalized
Acetylcholine receptor antibody (substance)
zilucoplan
technical report
---
https://ansm.sante.fr/tableau-acces-derogatoire/upstaza
2025
false
false
false
France
French
Eladocagene Exuparvovec
drug information
infant
Aromatic-L-Amino-Acid decarboxylases
Aromatic-L-Amino-Acid Decarboxylase
aromatic amino acid decarboxylase deficiency
technical report
---
https://ansm.sante.fr/tableau-acces-derogatoire/ivosidenib
2025
false
false
false
France
French
administration, oral
summary of product characteristics
cholangiocarcinoma
guidelines for drug use
leukemia, myeloid, acute
glioma
myelodysplastic syndromes
antineoplastic agents
ivosidenib
ivosidenib
neoplasm metastasis
package leaflet
antineoplastic combined chemotherapy protocols
---
https://www.has-sante.fr/jcms/p_3417653/fr/livtencity-maribavir-infection-a-cmv
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
maribavir
cytomegalovirus infections
antiviral agents
Product containing only maribavir (medicinal product)
adult
organ transplantation
hematopoietic stem cell transplantation
Refractory Cytomegalovirus Infection
administration, oral
evaluation of the transparency committee
maribavir
---
https://ansm.sante.fr/tableau-acces-derogatoire/tedopi
2025
false
false
false
France
French
drug information
insurance, health, reimbursement
injections, subcutaneous
cancer vaccines
Multi-neo-epitope Vaccine OSE 2101
---
https://ansm.sante.fr/tableau-acces-derogatoire/idefirix
2025
false
false
false
France
French
infusions, intravenous
imlifidase
Imlifidase
kidney transplantation
Anti-HLA hyperimmunization
drug information
---
https://ansm.sante.fr/tableau-marr/eladocagene-exuparvovec
2025
false
false
false
France
French
risk management
guidelines for drug use
Eladocagene Exuparvovec
drug compounding
Stereotactic surgery
stereotaxic techniques
gene therapy
Intraputaminal Route of Administration
aromatic amino acid decarboxylase deficiency
Injection of brain (procedure)
infusions, parenteral
neurosurgical procedures
patient education handout
guideline
eladocagene exuparvovec
---
https://ansm.sante.fr/tableau-marr/idecabtagene-vicleucel
2025
false
false
false
France
French
guidelines for drug use
popular works
risk management
idecabtagene vicleucel
idecabtagene vicleucel
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
drug compounding
idecabtagene vicleucel
gene therapy
immunotherapy, adoptive
idecabtagene vicleucel
continuity of patient care
nervous system diseases
infusions, intravenous
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
multiple myeloma
Cytokine Release Syndrome
Cytokine Release Syndrome
signs and symptoms
defrosting
---
https://ansm.sante.fr/tableau-acces-derogatoire/vutrisiran
2025
false
false
false
France
French
Vutrisiran
drug information
amyloidosis, hereditary, Transthyretin-Related
vutrisiran
---
https://ansm.sante.fr/tableau-marr/aflibercept
2025
false
false
false
France
French
guidelines for drug use
patients guideline
aflibercept
recombinant fusion proteins
receptors, vascular endothelial growth factor
Drug-Related side effects and adverse reactions
signs and symptoms
intravitreal injections
video recording
intravitreal injections
sound
---
https://ansm.sante.fr/tableau-acces-derogatoire/enfortumab-vedotin-padcev
2025
false
false
false
France
French
drug information
insurance, health, reimbursement
enfortumab vedotin
enfortumab vedotin
Locally Advanced Urothelial Carcinoma
carcinoma, transitional cell
urologic neoplasms
Metastatic Urothelial Carcinoma
neoplasm metastasis
Refractory Urothelial Carcinoma
infusions, intravenous
antineoplastic agents
antineoplastic combined chemotherapy protocols
pembrolizumab
Enfortumab Vedotin/Pembrolizumab Regimen
Unresectable Urothelial Carcinoma
---
https://ansm.sante.fr/tableau-acces-derogatoire/ursofalk-250-mg-5-ml-suspension-buvable
https://ansm.sante.fr/tableau-acces-derogatoire/ursofalk-250-mg-5-ml-suspension-buvable#
2025
false
false
false
France
French
ursodeoxycholic acid
guidelines for drug use
cystic fibrosis
Hepatobiliary Disorders
administration, oral
infant
child
technical report
---
https://ansm.sante.fr/tableau-acces-derogatoire/lioresal-10-mg-comprime-secable
2025
false
false
false
France
French
drug information
baclofen
Product containing precisely baclofen 1 milligram/1 milliliter conventional release
oral solution (clinical drug)
contracture
muscle spasticity
administration, oral
gastroesophageal reflux
Unable to swallow tablet (finding)
---
https://ansm.sante.fr/actualites/amoxicilline-des-recommandations-pour-contribuer-a-garantir-la-couverture-des-besoins-des-patients
2025
false
false
false
France
French
amoxicillin
guidelines for drug use
amoxicillin
administration, oral
infant
child
amoxicillin
amoxicillin-potassium clavulanate combination
amoxicillin-potassium clavulanate combination
amoxicillin and beta-lactamase inhibitor
---
https://ansm.sante.fr/tableau-marr/selexipag
2025
false
false
false
France
French
risk management
Uptravi
medication errors
selexipag
patients guideline
guidelines for drug use
Wrong dose
selexipag
---
https://ansm.sante.fr/tableau-marr/rivaroxaban
2025
false
false
false
France
French
Rivaroxaban
risk management
guidelines for drug use
continuity of patient care
administration, oral
medication errors
hemorrhage
Drug-Related side effects and adverse reactions
Rivaroxaban
package leaflet
video recording
---
https://ansm.sante.fr/tableau-marr/apixaban
2025
false
false
false
France
French
guidelines for drug use
risk management
apixaban
administration, oral
apixaban
continuity of patient care
hemorrhage
Drug-Related side effects and adverse reactions
patient education handout
---
https://ansm.sante.fr/tableau-acces-derogatoire/berinert-500-ui-mg-poudre-et-solvant-pour-solution-injectable-perfusion
2025
false
false
false
France
French
complement C1 inhibitor protein
guidelines for drug use
continuity of patient care
salvage therapy
graft rejection
Humoral rejection
heart transplantation
kidney transplantation
lung transplantation
infusions, intravenous
complement C1 inhibitor protein
technical report
---
https://ansm.sante.fr/tableau-acces-derogatoire/m-m-rvaxpro-priorix
2025
false
false
false
France
French
vaccination
infant
drug information
measles-mumps-rubella vaccine
Post-Exposure prophylaxis
measles
continuity of patient care
technical report
---
https://ansm.sante.fr/tableau-marr/lauromacrogol-400
2025
false
false
false
France
French
risk management
guidelines for drug use
Polidocanol
polidocanol
patients guideline
Polidocanol
Drug-Related side effects and adverse reactions
continuity of patient care
Polidocanol
drug compounding
---
https://ansm.sante.fr/tableau-acces-derogatoire/kimozo-40-mg-ml-suspension-buvable#
2025
false
false
false
France
French
administration, oral
antineoplastic agents, alkylating
Temozolomide
child
neuroblastoma
summary of product characteristics
package leaflet
guidelines for drug use
Refractory Neuroblastoma
Recurrent Neuroblastoma
High Risk Neuroblastoma
glioblastoma multiforme
anaplastic astrocytoma
Recurrent Childhood Anaplastic Astrocytoma
Refractory Anaplastic Astrocytoma
medulloblastoma
Recurrent Childhood Medulloblastoma
Refractory Medulloblastoma
sarcoma, ewing
Recurrent Ewing Sarcoma
Refractory Ewing Sarcoma
rhabdomyosarcoma
Recurrent Childhood Rhabdomyosarcoma
Refractory Childhood Rhabdomyosarcoma
---
https://ansm.sante.fr/tableau-acces-derogatoire/teclistamab
2025
false
false
false
France
French
drug information
Teclistamab
adult
multiple myeloma
Recurrent Multiple Myeloma
Refractory Multiple Myeloma
summary of product characteristics
package leaflet
antibodies, monoclonal
Antineoplastic Agents, Immunological
teclistamab
---
https://ansm.sante.fr/tableau-acces-derogatoire/xenpozyme#
2025
false
false
false
France
French
drug information
olipudase alfa
olipudase alfa
enzyme replacement therapy
child
adolescent
adult
niemann-pick diseases
---
https://ansm.sante.fr/tableau-acces-derogatoire/enhertu-100-mg-poudre-pour-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
summary of product characteristics
package leaflet
guidelines for drug use
Metastatic Gastric Adenocarcinoma
stomach neoplasms
adenocarcinoma
neoplasm metastasis
Locally Advanced Gastric Adenocarcinoma
Metastatic Gastroesophageal Junction Adenocarcinoma
Locally Advanced Gastroesophageal Junction Adenocarcinoma
HER2/Neu Positive
trastuzumab deruxtecan
infusions, intravenous
trastuzumab deruxtecan
Antineoplastic Agents, Immunological
breast neoplasms
Metastatic HER2-Positive Breast Carcinoma
Unresectable HER2-Positive Breast Carcinoma
Refractory HER2-Positive Breast Carcinoma
HER2-Low Breast Carcinoma
Metastatic HER2-Low Breast Carcinoma
neoplasm recurrence, local
---
https://ansm.sante.fr/tableau-acces-derogatoire/imfinzi-50-mg-ml-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
summary of product characteristics
package leaflet
durvalumab
guidelines for drug use
Unresectable Biliary Tract Carcinoma
antineoplastic combined chemotherapy protocols
Metastatic Biliary Tract Carcinoma
durvalumab
adult
Cisplatin/Durvalumab/Gemcitabine Regimen
infusions, intravenous
cisplatin
carcinoma, hepatocellular
carcinoma, non-small-cell lung
small cell lung carcinoma
bronchial neoplasms
---
https://ansm.sante.fr/tableau-acces-derogatoire/tebentafusp
2025
false
false
false
France
French
drug information
tebentafusp
uveal melanoma
---
https://www.has-sante.fr/jcms/p_3367704/fr/le-patient-en-auto-administration-de-ses-medicaments-en-cours-d-hospitalisation
2025
false
false
false
France
guideline
self administration
inpatients
---
https://ansm.sante.fr/tableau-marr/hemine-humaine
2025
false
false
false
France
French
risk management
hemin
guidelines for drug use
continuity of patient care
infusions, intravenous
Drug-Related side effects and adverse reactions
Injection Site Reaction
hemin
Drug Extravasation
thrombosis
---
https://ansm.sante.fr/tableau-acces-derogatoire/velcade-1-mg-poudre-pour-solution-injectable
2025
false
false
false
France
French
drug information
Bortezomib
injections, intravenous
Immunoglobulin Light-chain Amyloidosis
Non-amyloid monoclonal immunoglobulin deposition disease
---
https://ansm.sante.fr/tableau-acces-derogatoire/xalkori
2025
false
false
false
France
French
drug information
administration, oral
Crizotinib
antineoplastic agents
protein kinase inhibitors
capsules
pharmaceutical solutions
child
infant
lymphoma, large-cell, anaplastic
Childhood Anaplastic Large Cell Lymphoma, ALK-Positive
crizotinib
MET Exon 14 Mutation
Locally Advanced Lung Non-Small Cell Carcinoma
adult
Metastatic Lung Non-Small Cell Carcinoma
carcinoma, non-small-cell lung
continuity of patient care
---
https://ansm.sante.fr/tableau-marr/cladribine
2025
false
false
false
France
French
risk management
cladribine
administration, oral
cladribine
immunosuppressive agents
cladribine
guidelines for drug use
patients guideline
Drug-Related side effects and adverse reactions
adult
multiple sclerosis, relapsing-remitting
continuity of patient care
hematologic tests
---
https://ansm.sante.fr/tableau-marr/inebilizumab
2025
false
false
false
France
French
risk management
inebilizumab
inebilizumab
infusions, intravenous
patients guideline
product surveillance, postmarketing
patient safety
adult
neuromyelitis optica
Immunosuppression-related infectious disease (disorder)
leukoencephalopathy, progressive multifocal
virus diseases
serious infection
---
https://ansm.sante.fr/tableau-acces-derogatoire/imcivree#
2025
false
false
false
France
French
setmelanotide
adult
adolescent
child
obesity
obesity
bardet-biedl syndrome
continuity of patient care
drug monitoring
product surveillance, postmarketing
setmelanotide
injections, subcutaneous
guidelines for drug use
package leaflet
summary of product characteristics
technical report
---
https://www.ema.europa.eu/en/medicines/human/EPAR/rybrevant
2025
false
false
false
Netherlands
French
English
amivantamab
amivantamab
amivantamab
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
rybrevant
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
adult
aged
carcinoma, non-small-cell lung
bronchial neoplasms
Activating EGFR Exon 20 Mutation
carcinoma, non-small-cell lung
bronchial neoplasms
Gain of Function Mutation
genes, erbb-1
Refractory Lung Non-Small Cell Carcinoma
infusions, intravenous
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
Non-small cell lung cancer with mutation in epidermal growth factor receptor (disorder)
advanced non-small cell lung cancer with activating epidermal growth factor receptor
exon 20 insertion mutations
EGFR Exon 19 Deletion Mutation
EGFR NP_005219.2:p.L858R
---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/imogam-rage-150-ui-ml-solution-injectable-immunoglobuline-humaine-rabique
2025
false
false
false
France
French
drug information
rabies vaccines
rabies
Human Rabies Virus Immune Globulin
vaccination
rabies immunoglobulin
Post-Exposure prophylaxis
Drug Recalls
---
https://ansm.sante.fr/tableau-acces-derogatoire/kaftrio-75-mg-50-mg-100-mg-comprime-pellicule-kalydeco-150-mg-comprime-pellicule
2025
false
false
false
France
French
cystic fibrosis
guidelines for drug use
continuity of patient care
drug therapy, combination
administration, oral
ivacaftor, tezacaftor and elexacaftor
elexacaftor, ivacaftor, tezacaftor drug combination
ivacaftor
tezacaftor
elexacaftor
adult
adolescent
ivacaftor
trikafta
drug combinations
drug information
---
https://ansm.sante.fr/tableau-acces-derogatoire/thalidomide-bms-50-mg-gelule
2025
false
false
false
France
French
guidelines for drug use
continuity of patient care
thalidomide
administration, oral
Jessner lymphocytic infiltration of the skin
lupus erythematosus, cutaneous
stomatitis, aphthous
Immune complex reaction co-occurrent and due to multibacillary leprosy (disorder)
crohn disease
erythema multiforme
Erythema multiforme major
technical report
---
https://ansm.sante.fr/tableau-acces-derogatoire/lutathera
2025
false
false
false
France
French
infusions, intravenous
drug information
lutetium (177Lu) oxodotreotide
lutetium Lu 177 dotatate
radiopharmaceuticals
guidelines for drug use
Pheochromocytoma-paraganglioma
pheochromocytoma
Metastatic Lung Neuroendocrine Tumor
bronchial neoplasms
neoplasm metastasis
Thymic neuroendocrine tumor
neuroendocrine tumors
thymus neoplasms
Metastatic Thymus Neuroendocrine Neoplasm
meningioma
Somatostatin Receptor Positive
Somatostatin Receptor 2 Positive
technical report
---
https://ansm.sante.fr/tableau-marr/methoxyflurane
2025
false
false
false
France
French
risk management
methoxyflurane
administration, inhalation
guidelines for drug use
methoxyflurane
methoxyflurane
Drug-Related side effects and adverse reactions
emergency treatment
pain
wounds and injuries
Post-traumatic pain
---
https://ansm.sante.fr/tableau-marr/adrenaline-3
2025
false
false
false
France
French
risk management
epinephrine
guidelines for drug use
self administration
injections, intramuscular
epinephrine
anaphylaxis
patients guideline
drug storage
video recording
epinephrine
---
https://ansm.sante.fr/tableau-atu-rtu/gymiso-200-microgrammes-comprime-2
2025
false
false
false
France
French
misoprostol
guidelines for drug use
abortion, Drug-Induced
abortifacient agents, nonsteroidal
misoprostol
drug therapy, combination
mifepristone
drug information
---
https://ansm.sante.fr/actualites/immunoglobulines-sous-cutanees-recommandations-dutilisation-chez-les-patients-atteints-de-pidc-dans-un-contexte-de-tension-dapprovisionnement
2025
false
false
false
France
French
guidelines for drug use
immunoglobulins
injections, subcutaneous
polyradiculoneuropathy, chronic inflammatory demyelinating
immunoglobulins, normal human, for extravascular adm.
immunoglobulins
immunoglobulins
---
https://ansm.sante.fr/tableau-atu-rtu/primaquine-sanofi-15-mg-comprime-pellicule
2025
false
false
false
France
French
primaquine
primaquine
malaria, vivax
Ovale malaria (disorder)
recurrence
administration, oral
antimalarials
pneumonia, pneumocystis
Product containing precisely primaquine (as primaquine phosphate) 15 milligram/1 each
conventional release oral tablet (clinical drug)
Product containing precisely primaquine (as primaquine phosphate) 7.5 milligram/1
each conventional release oral tablet (clinical drug)
technical report
drug information
---
https://ansm.sante.fr/tableau-marr/etonogestrel
2025
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
patient education handout
etonogestrel
drug implants
Insertion of etonogestrel radiopaque contraceptive implant (procedure)
Removal of etonogestrel radiopaque contraceptive implant (procedure)
Insertion of subcutaneous contraceptive in arm (procedure)
etonogestrel
contraceptive agents, female
progestins
Migration of implanted drug
Surveillance of subcutaneous contraceptive implant (regime/therapy)
---
https://ansm.sante.fr/tableau-atu-rtu/177lu-lu-psma-617-solution-injectable-pour-perfusion
2025
false
false
false
France
French
Lutetium Lu 177 Vipivotide Tetraxetan
Pluvicto
drug information
lutetium (177Lu) vipivotide tetraxetan
---
https://www.santepubliquefrance.fr/regions/bretagne/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-bretagne
2025
France
technical report
health
appraiser
Respect
air pollution, indoor
air, nos
quality improvement
Air Quality
---
https://www.santepubliquefrance.fr/regions/centre-val-de-loire/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-centre-val-de-loire
2025
France
technical report
Air Quality
quality improvement
air, nos
Respect
air pollution, indoor
health
central
valine
appraiser
---
https://www.santepubliquefrance.fr/regions/grand-est/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-grand-est
2025
France
technical report
appraiser
Air Quality
prion diseases
health
air pollution, indoor
Respect
quality improvement
air, nos
---
https://www.santepubliquefrance.fr/regions/hauts-de-france/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-hauts-de-france
2025
France
technical report
Air Quality
appraiser
Respect
health
air pollution, indoor
air, nos
quality improvement
france
french
---
https://www.santepubliquefrance.fr/regions/normandie/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-normandie
2025
France
technical report
health
air pollution, indoor
Air Quality
appraiser
air, nos
quality improvement
Respect
---
https://www.santepubliquefrance.fr/regions/nouvelle-aquitaine/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-nouvelle-aquitaine
2025
France
technical report
Air Quality
health
air, nos
quality improvement
air pollution, indoor
Respect
appraiser
---
https://www.santepubliquefrance.fr/regions/occitanie/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-occitanie
2025
France
technical report
Respect
appraiser
quality improvement
air, nos
health
Air Quality
air pollution, indoor
---
https://www.santepubliquefrance.fr/regions/pays-de-la-loire/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-pays-de-la-loire
2025
France
technical report
quality improvement
appraiser
air pollution, indoor
Respect
Air Quality
air, nos
health
---
https://www.santepubliquefrance.fr/regions/provence-alpes-cote-d-azur-et-corse/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-corse
2025
France
technical report
appraiser
air pollution, indoor
corsica
Air Quality
Respect
france
health
quality improvement
air, nos
---
https://www.santepubliquefrance.fr/regions/provence-alpes-cote-d-azur-et-corse/documents/rapport-synthese/2025/estimation-des-benefices-potentiels-pour-la-sante-d-une-amelioration-de-la-qualite-de-l-air-ambiant-en-provence-alpes-cote-d-azur
2025
France
technical report
quality improvement
air pollution, indoor
health
appraiser
air, nos
unilateral
Respect
ribs
Air Quality
---
https://beh.santepubliquefrance.fr/beh/2025/3-4/2025_3-4_4.html
2025
France
journal article
malignant neoplasm colon/rectum
Respect
france
french
Colorectal Cancer
insurance coverage
colorectal neoplasms
early detection of cancer
screening for cancer
cancer screening
appraiser
---
https://kce.fgov.be/fr/publications/tous-les-rapports/developpement-academique-de-medicaments-de-therapie-innovante-atmp-en-belgique-considerations
2025
Belgium
technical report
french abstract
drug, nos
Drug Development
innovative therapies
belgium
Academia
academies
therapy, nos
academies and institutes
drug therapy
therapies, investigational
---
https://minerva-ebp.be/FR/Article/2421
2025
Belgium
critical appraisal or critical reading
counseling
treatment outcome
placebos
orthotic devices
exercise
Treatment Efficacy
---
https://www.cbip.be/fr/articles/4494?folia=4486
2025
false
false
false
Belgium
French
journal article
drug information
dipyrone
agranulocytosis
risk
---
https://ansm.sante.fr/informations-de-securite/specialites-contenant-du-thiocolchicoside-rappels-et-nouvelles-recommandations-concernant-le-risque-potentiel-de-genotoxicite?
2025
false
false
false
France
French
pharmacovigilance note
risk management
thiocolchicoside
Genotoxicity
administration, oral
injections, intramuscular
thiocolchicoside
Male
thiocolchicoside
---
https://ansm.sante.fr/tableau-marr/thiocolchicoside
2025
false
false
false
France
French
risk management
thiocolchicoside
patient education handout
guidelines for drug use
thiocolchicoside
fetus
Genotoxicity
administration, oral
injections, intramuscular
pregnancy
breast feeding
Male
female
thiocolchicoside
contraception
---
https://www.cbip.be/fr/articles/4483?folia=4464
2025
false
false
false
Belgium
French
journal article
drug information
belgium
ibuprofen
Delayed-Action preparations
administration, oral
Product containing precisely ibuprofen 800 milligram/1 each conventional release oral
tablet (clinical drug)
Product containing precisely ibuprofen 800 milligram/1 each prolonged-release oral
tablet (clinical drug)
ibuprofen
---
https://ansm.sante.fr/actualites/vaccins-contre-le-covid-19-les-rapports-denquete-confirment-de-nouveau-leur-profil-de-securite
2025
false
false
false
France
French
COVID-19 Vaccines
product surveillance, postmarketing
health surveys
drug information
COVID-19 Vaccines
vaccination
COVID-19
pregnancy
breast feeding
Covid-19 vaccines
adverse drug reaction reporting systems
france
---
https://ansm.sante.fr/actualites/decision-du-31-01-2025-modification-de-la-liste-mentionnee-au-1deg-de-larticle-l-5126-6-du-code-de-la-sante-publique
2025
false
false
false
France
French
drug information
---
https://ansm.sante.fr/tableau-acces-derogatoire/adagrasib
2025
false
false
false
France
French
administration, oral
drug information
antineoplastic agents
adagrasib
adagrasib
---
https://ansm.sante.fr/tableau-acces-derogatoire/zanidatamab
2025
false
false
false
France
French
infusions, intravenous
zanidatamab
drug information
summary of product characteristics
package leaflet
adult
biliary tract neoplasms
HER2 positive biliary tract cancer
HER2/Neu Expression by Immunohistochemistry 3+
zanidatamab
Locally Advanced Bile Duct Carcinoma
Metastatic Bile Duct Carcinoma
Unresectable Bile Duct Carcinoma
guidelines for drug use
---
https://ansm.sante.fr/tableau-marr/sel-de-fer-injectable
2025
false
false
false
France
French
risk management
iron compounds
iron, parenteral preparations
patient education handout
guidelines for drug use
injections, intravenous
infusions, intravenous
iron compounds
anaphylaxis
drug hypersensitivity
Drug-Related side effects and adverse reactions
---
https://www.has-sante.fr/jcms/c_2664184/fr/systemes-d-aide-a-la-decision-indexee-par-medicaments-sam
2025
false
false
false
France
French
decision making, computer-assisted
scientific and technical information
pharmaceutical preparations
Drug-Related side effects and adverse reactions
---
https://www.cbip.be/fr/articles/4475?folia=4464
2025
false
false
false
Belgium
French
pharmacovigilance note
journal article
Olmesartan Medoxomil
Adverse reaction caused by olmesartan (disorder)
risk
intestinal diseases
---
https://ansm.sante.fr/actualites/plan-hivernal-premier-point-de-situation-2025-sur-lapprovisionnement-de-certains-medicaments-majeurs-de-lhiver
2025
false
false
false
France
French
anti-bacterial agents
france
drug information
---
https://www.reiso.org/articles/themes/pratiques/13536-des-presences-actives-recette-du-vivre-ensemble
2025
Switzerland
journal article
activir
recipes
activator appliances
---
http://beh.santepubliquefrance.fr/beh/2025/1/2025_1_1.html
2025
France
journal article
appraiser
Vaccination Coverage
Balance Sheet
school health services
Respect
scales
weights and measures
ladder, nos
health
feasibility studies
due to
---
https://www.calameo.com/onco-occitanie/read/0071780926f9da30c68d6
2025
France
guideline
drug, nos
home care services, hospital-based
drug therapy
cancer
neoplasms
neoplasm, malignant
---
https://www.has-sante.fr/jcms/p_3575020/fr/tecartus-brexucabtagene-autoleucel-lymphome-a-cellules-du-manteau-lcm
2025
false
false
false
France
evaluation of the transparency committee
antigens, CD19
"u" lymphocyte
brexucabtagene autoleucel
brexucabtagene autoleucel
cells
---
https://www.has-sante.fr/jcms/p_3576429/fr/trumenba-vaccin-meningococcique-groupe-b-recombinant-adsorbe-vaccin-anti-meningococcique-serogroupe-b
2025
false
false
false
France
Meningococcal group B vaccine (product)
evaluation of the transparency committee
vaccines, recombinant
vaccination
Serogroup
preventive immunization/medication
neisseria meningitidis
meningococcal vaccines
vaccines, synthetic
vaccine, nos
population groups
---
https://www.has-sante.fr/jcms/p_3576072/fr/padcev-enfortumab-vedotin-carcinome-urothelial
2025
false
false
false
France
Urothelial Carcinoma
evaluation of the transparency committee
enfortumab vedotin
carcinoma
enfortumab vedotin
---
https://www.has-sante.fr/jcms/p_3577021/fr/vabysmo-faricimab-oedeme-maculaire-secondaire-a-une-occlusion-de-branche-veineuse-retinienne-obvr-ou-de-la-veine-centrale-de-la-retine-ovcr
2025
false
false
false
France
faricimab
vision disorders
Central Retinal Vein Occlusion
intravitreal injections
adult
evaluation of the transparency committee
macular edema
faricimab
retinal vein occlusion
Branch Vein Occlusion
---
https://ansm.sante.fr/tableau-marr/paracetamol
2025
false
false
false
France
French
risk management
acetaminophen
infusions, intravenous
guidelines for drug use
clinical tool
---
https://www.has-sante.fr/jcms/p_3556159/fr/dupixent-dupilumab-bronchopneumopathie-chronique-obstructive-bpco
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
injections, subcutaneous
evaluation of the transparency committee
dupilumab
pulmonary disease, chronic obstructive
---
https://ansm.sante.fr/tableau-acces-derogatoire/rezlidhia
2025
false
false
false
France
French
drug information
olutasidenib
olutasidenib
leukemia, myeloid, acute
Refractory Acute Myeloid Leukemia
Recurrent Acute Myeloid Leukemia
adult
leukemia, myeloid, acute
IDH1 Gene Mutation
IDH1 inhibitor
summary of product characteristics
---
https://ansm.sante.fr/actualites/analogues-du-glp-1-et-obesite-nous-prenons-des-mesures-pour-securiser-leur-utilisation-en-france
2025
false
false
false
France
French
patient safety
Glucagon-Like Peptide-1 Receptor Agonists
obesity
france
Drug Misuse
prescription drug misuse
drug prescriptions
critical pathways
semaglutide
pharmacovigilance note
guideline
Tirzepatide
Liraglutide
legislation, pharmacy
---
https://ansm.sante.fr/tableau-marr/etrasimod
2025
false
false
false
France
French
risk management
administration, oral
etrasimod
continuity of patient care
guidelines for drug use
patient education handout
pregnancy
patients guideline
Upfront Treatment
Drug Exposure
etrasimod
Etrasimod Arginine
---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/tsoludose-solution-buvable-en-recipient-unidose-levothyroxine
2025
false
false
false
France
French
pharmaceutical solutions
administration, oral
levothyroxine sodium
levothyroxine sodium
drug information
---
https://www.has-sante.fr/jcms/p_3542801/fr/blincyto-blinatumomab-leucemie-aigue-lymphoblastique
2025
false
false
false
France
blinatumomab
antineoplastic agents
adult
treatment outcome
insurance, health, reimbursement
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Measurable Residual Disease Negativity
consolidation chemotherapy
evaluation of the transparency committee
precursor cell lymphoblastic Leukemia-Lymphoma
blinatumomab
---
https://ansm.sante.fr/tableau-marr/paracetamol-iv-2
2025
false
false
false
France
French
acetaminophen
infusions, intravenous
administration, intravenous
guidelines for drug use
clinical tool
Wrong dose
medication errors
---
https://ansm.sante.fr/tableau-marr/mavacamten
2025
false
false
false
France
French
risk management
mavacamten
mavacamten
mavacamten
administration, oral
patients guideline
guidelines for drug use
fetus
pregnancy
embryo
drug interactions
heart failure, systolic
Fetal exposure to drug (situation)
Cytochrome P-450 CYP2C19 Inhibitors
Cytochrome P-450 CYP3A4 Inhibitors
Cytochrome P450 family 2 subfamily C member 19 intermediate metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 ultra-rapid metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 poor metabolizer (finding)
Cytochrome P450 family 2 subfamily C member 19 normal metabolizer (finding)
patient education handout
---
https://ansm.sante.fr/actualites/analogues-du-glp-1-et-diabete-de-type-2-reprise-progressive-des-initiations-de-traitement-pour-ozempic-et-victoza
2025
false
false
false
France
French
patient education handout
guideline
drug information
Glucagon-Like Peptide-1 Receptor Agonists
diabetes mellitus, type 2
Glucagon-like peptide-1 (GLP-1) analogues
Pharmacotherapy Initiation
Pharmacotherapy Continuation
dulaglutide
semaglutide
Liraglutide
---
https://ansm.sante.fr/tableau-acces-derogatoire/avastin-r-25-mg-ml-solution-a-diluer-pour-perfusion
2025
false
false
false
France
French
Bevacizumab
drug information
guidelines for drug use
telangiectasia, hereditary hemorrhagic
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-disponibilite-de-tsoludose-solution-buvable-en-recipient-unidose
2025
false
false
false
France
French
drug information
thyroxine
levothyroxine sodium
administration, oral
pharmaceutical solutions
patients guideline
guideline
---
https://ansm.sante.fr/actualites/tensions-dapprovisionnement-en-stylo-dadrenaline-anapen-recommandations-et-disponibilites-des-autres-stylos
2025
false
false
false
France
French
epinephrine
france
Epinephrine autoinjector (physical object)
drug information
epinephrine
guideline
---
https://ansm.sante.fr/tableau-marr/zilucoplan
2025
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
injections, subcutaneous
zilucoplan
Drug-Related side effects and adverse reactions
zilucoplan
complement inactivating agents
vaccination
meningococcal infections
meningococcal vaccines
guideline
---
https://ansm.sante.fr/tableau-acces-derogatoire/onpattro
2025
false
false
false
France
French
patisiran
drug information
guidelines for drug use
infusions, intravenous
Wild type ATTR amyloidosis
Hereditary ATTR amyloidosis
Cardiac ATTR Amyloidosis
amyloidosis
Transthyretin
---
https://ansm.sante.fr/tableau-acces-derogatoire/balversa-erdafitinib
2025
false
false
false
France
French
drug information
erdafitinib
administration, oral
erdafitinib
---
https://ansm.sante.fr/tableau-acces-derogatoire/gymiso-200-microgrammes-comprime-1
2025
false
false
false
France
French
misoprostol
mifepristone
drug information
continuity of patient care
abortion, legal
---
https://ansm.sante.fr/tableau-acces-derogatoire/namuscla-167-mg-gelule
2025
false
false
false
France
French
drug information
mexiletine
guidelines for drug use
adult
myotonic dystrophy
---
https://ansm.sante.fr/actualites/rifampicine-conduites-a-tenir-dans-un-contexte-de-fortes-tensions-dapprovisionnement
2025
false
false
false
France
French
rifampin
france
administration, oral
infusions, intravenous
guidelines for drug use
antibiotics, antitubercular
-
-
-
osteoarticular infections
tuberculosis
Infection associated with device (disorder)
Infection associated with vascular device (disorder)
Staphylococcal endocarditis (disorder)
---
https://ansm.sante.fr/tableau-acces-derogatoire/sotatercept
2025
false
false
false
France
French
sotatercept
recombinant fusion proteins
Pulmonary Arterial Hypertension
drug information
Pulmonary arterial hypertension WHO functional class III
Pulmonary arterial hypertension WHO functional class II
insurance, health, reimbursement
adult
sotatercept
---
https://ansm.sante.fr/tableau-marr/sutimlimab
2025
false
false
false
France
French
risk management
sutimlimab
guidelines for drug use
sutimlimab
antibodies, monoclonal, humanized
infusions, intravenous
Infections
Infections
meningococcal vaccines
meningococcal infections
vaccination
serious infection
patient education handout
---
https://ansm.sante.fr/tableau-acces-derogatoire/altuvoct
2025
false
false
false
France
French
Efanesoctocog Alfa
drug information
hemophilia A
hemorrhage
hemorrhage
---
https://ansm.sante.fr/tableau-marr/tafamidis
2025
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related
---
https://ansm.sante.fr/tableau-acces-derogatoire/casgevy
2025
false
false
false
France
French
biological products
exagamglogene autotemcel
Exagamglogene Autotemcel
risk management
beta-Thalassemia
Transfusion Dependent Beta Thalassemia
adolescent
adult
Cell positive for CD34 antigen (cell)
infusions, intravenous
young adult
anemia, sickle cell
drug information
---
https://ansm.sante.fr/tableau-marr/fentanyl-6
2025
false
false
false
France
French
fentanyl
Fentanyl Citrate
risk management
administration, sublingual
guidelines for drug use
fentanyl
patients guideline
adult
breakthrough pain
drug prescriptions
narcotics
Cancer Pain
---
https://ansm.sante.fr/tableau-acces-derogatoire/tak-755
2025
false
false
false
France
French
Apadamtase Alfa
congenital thrombotic thrombocytopenic purpura
enzyme replacement therapy
ADAMTS13 Protein
purpura, thrombotic thrombocytopenic
child
adolescent
adult
drug information
technical report
---
https://ansm.sante.fr/actualites/difficultes-dapprovisionnement-en-methylphenidate-lansm-publie-des-recommandations-pour-les-pharmaciens
2025
false
false
false
France
French
drug information
guideline
methylphenidate
methylphenidate
patient education handout
administration, oral
drug substitution
---
https://ansm.sante.fr/tableau-acces-derogatoire/omaveloxolone
2025
false
false
false
France
French
insurance, health, reimbursement
Omaveloxolone
administration, oral
adult
adolescent
friedreich ataxia
drug information
omaveloxolone
---
https://publications.msss.gouv.qc.ca/msss/document-003676/
2025
false
false
false
Canada
guidelines for drug use
Transference
Ambulatory Care Facility
Usage
Clinical Data
Countertransference
Transfer, Psychology
Healthcare Activity
Intervention for Congenital Heart Disease
Clinical Batch
clinical protocols
Healthcare
Clinical Lot
Transfer
nursing
Care
On Study
Clinical Study Protocol
How True Feel Carefree Right Now Question
Intervention
Transfer Ability Question
Stooping
---
https://ansm.sante.fr/tableau-acces-derogatoire/concizumab
2025
false
false
false
France
French
concizumab
guidelines for drug use
summary of product characteristics
package leaflet
technical report
hemophilia A
hemophilia B
hemorrhage
adolescent
---
https://ansm.sante.fr/dossiers-thematiques/plan-hivernal
2025
false
false
false
France
French
guideline
anti-bacterial agents
glucocorticoids
anti-asthmatic agents
continuity of patient care
break in supply
Drug Shortage
antipyretics
Product supply issue
drug information
---
https://publications.msss.gouv.qc.ca/msss/document-002057/
2025
false
false
false
Canada
patient education handout
leaves, nos
Person Info
vaccination
preventive immunization/medication
vaccine, nos
vaccination, nos
persons
Vaccination
toilet facilities
vaccinia
Vaccinated
Vaccine
vaccination
vaccinia, nos
Personal Information
Leaf
vaccines
---
https://www.has-sante.fr/jcms/p_3590639/fr/imfinzi-lynparza-durvalumab/olaparib-cancer-de-l-endometre
2025
false
false
false
France
antineoplastic combined chemotherapy protocols
insurance, health, reimbursement
treatment outcome
Antineoplastic Agents, Immunological
Advanced Endometrial Carcinoma
Recurrent Endometrial Carcinoma
Mismatch Repair Proficient
Mismatch Repair Deficiency
durvalumab
durvalumab
olaparib
olaparib
evaluation of the transparency committee
endometrial neoplasms
---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/elvorine-25-mg-2-5-ml-50-mg-5-ml-100-mg-10-ml-et-175-mg-17-5-ml-solution-injectable-levofolinate-de-calcium
2025
false
false
false
France
French
drug information
leucovorin, calcium (1:1) salt, (S)-Isomer
levoleucovorin
---
https://www.cbip.be/fr/articles/4491?folia=4486
2025
false
false
false
Belgium
French
aged
journal article
drug information
drug interactions
analgesics, opioid
Cytochrome P-450 CYP2D6 Inhibitors
Pharmacokinetics: Drug Interactions
antidepressive agents
---
https://ansm.sante.fr/tableau-marr/tolcapone
2025
false
false
false
France
French
risk management
continuity of patient care
Chemical and Drug Induced Liver Injury
neuroleptic malignant syndrome
Tolcapone
tolcapone
liver function tests
drug information
patient education handout
---
https://ansm.sante.fr/actualites/fluoroquinolones-nous-rappelons-limportance-du-bon-usage-de-ces-antibiotiques
2025
false
false
false
France
French
guidelines for drug use
fluoroquinolones
fluoroquinolones
anti-bacterial agents
anti-bacterial agents
administration, oral
injections
fluoroquinolones
Off-Label use
drug interactions
technical report
pharmacovigilance
france
Drug-Related side effects and adverse reactions
ciprofloxacin
levofloxacin
ofloxacin
norfloxacin
Moxifloxacin
lomefloxacin
delafloxacin
---
https://ansm.sante.fr/tableau-marr/tremelimumab
2025
false
false
false
France
French
tremelimumab
tremelimumab
risk management
drug information
patient education handout
Immune-Mediated Adverse Reaction
Drug-Related side effects and adverse reactions
signs and symptoms
Drug-Related side effects and adverse reactions
---
https://minerva-ebp.be/Theme/Analysis/891
2025
Belgium
critical appraisal or critical reading
patient care management
pharmacology
pharmacologist
drug therapy
panic
panic disorder
---
https://minerva-ebp.be/Theme/Analysis/893
2025
Belgium
critical appraisal or critical reading
general practice
illegal drug, nos
drug addicts
attention
patients
Outcome Expectations
Illicit Drugs
has patient
attention, nos
---
https://www.cancer.fr/presse/renforcer-la-securisation-medicamenteuse-des-patients-sous-anticancereux-injectables
2025
France
guideline
antineoplastic agents
injections
patients
hospitalization
drug therapy
hospital, nos
day care center
has patient
hospitals
administration of therapeutic substance, nos
---
https://www.cochrane.org/fr/CD013722/CENTRALED_quels-sont-les-effets-des-interventions-sur-les-ventes-de-medicaments-antimicrobiens-sans-ordonnance
2025
United Kingdom
review of literature
french abstract
community pharmacies
microbicides
nonprescription drugs
prescription drugs
prescription drug, nos
drug action, nos
sales
pharmacies
anti-infective agents
---
https://www.has-sante.fr/jcms/p_3588029/fr/promus-premier-btk-promus-premier-otw-btk-et-promus-premier-monorail-btk
2025
France
health technology assessment
Everolimus
Drug-Eluting stents
everolimus
Endoprosthesis
---
https://www.inserm.fr/actualite/les-medicaments-antiviraux-pourraient-contribuer-a-juguler-une-future-pandemie/
2025
France
popular works
pandemics
drug, nos
forecasting
antiviral agents
future
---
https://ansm.sante.fr/actualites/campagne-vaccinale-contre-les-infections-a-papillomavirus-humains-hpv-lensemble-des-donnees-disponibles-a-ce-jour-confirment-que-le-vaccin-gardasil-9-est-sur-et-efficace
2025
false
false
false
France
French
drug information
technical report
vaccine potency
papillomavirus vaccines
Human Papillomavirus Infection
vaccination
france
continuity of patient care
adolescent
guideline
patient safety
---
https://www.calameo.com/onco-occitanie/read/00717809236de148a34fb
2025
France
scientific and technical information
drug therapy
neoplasms
drug, nos
cancer
home care services, hospital-based
neoplasm, malignant
---
https://www.has-sante.fr/jcms/p_3590908/fr/chlorure-de-sodium-aguettant-chlorure-de-sodium-solute
2025
false
false
false
France
evaluation of the transparency committee
solutions
urine chloride
sodium chloride
sodium chloride
solution, nos
---
https://www.has-sante.fr/jcms/p_3592928/fr/amvuttra-vutrisiran-amylose-hereditaire-a-transthyretine-avec-cardiomyopathie
2025
false
false
false
France
amyloid neuropathies, familial
evaluation of the transparency committee
amylose
amyloidosis, hereditary, Transthyretin-Related
cardiomyopathies
---
https://www.has-sante.fr/jcms/p_3592985/fr/elahere-mirvetuximab-soravtansine-cancer-de-l-ovaire
2025
false
false
false
France
insurance, health, reimbursement
mirvetuximab soravtansine
infusions, intravenous
adult
fallopian tube neoplasms
peritoneal neoplasms
Folate Receptor Alpha Positive
evaluation of the transparency committee
ovarian neoplasms
mirvetuximab soravtansine
---
https://ansm.sante.fr/tableau-acces-derogatoire/tepezza
2025
false
false
false
France
French
summary of product characteristics
guidelines for drug use
insurance, health, reimbursement
tepezza
teprotumumab
teprotumumab
graves ophthalmopathy
graves disease
myxedema
infusions, intravenous
technical report
---
https://ansm.sante.fr/actualites/tramadol-et-codeine-les-nouvelles-regles-de-prescription-et-delivrance-entrent-en-vigueur-le-1er-mars-2025
2025
false
false
false
France
French
drug information
guideline
tramadol
codeine
legislation, pharmacy
drug prescriptions
popular works
---
https://www.cbip.be/fr/articles/4490?folia=4486
2025
false
false
false
Belgium
French
drug information
journal article
adrenergic beta-antagonists
myocardial infarction
treatment outcome
---
https://www.lecrat.fr/3147/
2025
false
false
false
France
French
pregnancy
fetus
teratogens
abnormalities, drug-induced
drug information
directory
---
https://www.ema.europa.eu/en/medicines/human/EPAR/penbraya
2025
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
---
https://ansm.sante.fr/tableau-acces-derogatoire/elahere
2025
false
false
false
France
French
insurance, health, reimbursement
mirvetuximab soravtansine
mirvetuximab soravtansine
drug information
immunoconjugates
antibodies, monoclonal, humanized
maytansine
Antineoplastic Agents, Immunological
Folate Receptor Alpha Positive
ovarian neoplasms
peritoneal neoplasms
fallopian tube neoplasms
---
https://www.legifrance.gouv.fr/jorf/id/JORFTEXT000051253918
2025
false
false
false
France
French
legislation
biosimilar pharmaceuticals
legislation, pharmacy
drug substitution
directory
---
https://anap.fr/s/article/empreinte-carbone-medicaments
2025
France
handbooks
carbon footprint
drug, nos
drug evaluation
carbon, nos
---
https://pgtm.qc.ca/wp-content/uploads/2025/02/re_importance-clinique-des-nmp-et-te-280225.pdf
2025
Canada
guidelines for drug use
Clinical Relevance
drug, nos
private physicians' group office
drug therapy
---
https://www.has-sante.fr/jcms/p_3593981/fr/epidemie-de-chikungunya-utilisation-du-vaccin-ixchiq-a-la-reunion-et-a-mayotte
2025
France
public health guidelines
vaccines
Chikungunya Fever
disease outbreaks
Off-Label use
vaccination
vaccination
group processes
preventive immunization/medication
vaccine, nos
comoros
vaccinia
mayotte
epidemics
---
https://www.has-sante.fr/jcms/p_3576495/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg
2025
false
false
false
France
insurance, health, reimbursement
treatment outcome
Generalized pustular psoriasis
Generalized pustular psoriasis flare
spesolimab
adult
adolescent
evaluation of the transparency committee
psoriasis
spesolimab
---
https://www.has-sante.fr/jcms/p_3574834/fr/tibsovo-ivosidenib-cancer-voies-biliaires
2025
false
false
false
France
locally advanced or metastatic cholangiocarcinoma with an IDH1 R132 mutation
evaluation of the transparency committee
ivosidenib
ivosidenib
biliary tract, nos
neoplasm, malignant
Tibsovo
biliary tract neoplasms
biliary tract cancer
---
https://www.has-sante.fr/jcms/p_3576108/fr/adzynma-apadamtase-alfa-purpura-thrombotique-thrombocytopenique-congenital-pttc-pediatrie
2025
false
false
false
France
child
treatment outcome
insurance, health, reimbursement
Apadamtase Alfa
guidelines for drug use
apadamtase alfa and cinaxadamtase alfa
Cinaxadamtase Alfa
enzyme replacement therapy
ADAMTS13 protein, human
injections, intravenous
evaluation of the transparency committee
purpura, thrombotic thrombocytopenic
congenital thrombotic thrombocytopenic purpura
---
https://www.has-sante.fr/jcms/p_3508311/fr/winrevair-sotatercept-hypertension-arterielle-pulmonaire
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug therapy, combination
sotatercept
evaluation of the transparency committee
Pulmonary Arterial Hypertension
sotatercept
---
https://www.has-sante.fr/jcms/p_3576306/fr/imfinzi-durvalumab-et-lynparza-olaparib-en-association-cancer-de-l-endometre
2025
false
false
false
France
evaluation of the transparency committee
olaparib
cancer
Imfinzi
endometrial neoplasms
durvalumab
Lynparza
endometrium
neoplasm, malignant
olaparib
association
olaparib
durvalumab
Endomet
---
https://www.has-sante.fr/jcms/p_3576102/fr/sam-de-l-ansm-sur-le-valproate-modification-des-conditions-de-prescription-et-de-delivrance-cpd-pour-les-patients-adolescents-et-hommes-afin-de-limiter-les-risques-potentiels-de-troubles-neurodeveloppementaux-pour-les-enfants-a-naitre-lies-a-l-exposition-paternelle-dans-les-trois-mois-precedant-la-conception
2025
France
evaluation of the transparency committee
indexing
medical futility
child
conception
meconium aspiration syndrome
adolescence
patients
macrophage activation syndrome
risk
paternal exposure
prescription, nos
men
adolescent
Neurodevelopmental Disorders
decision support techniques
father, nos
drug design
operations research
drug, nos
valproic acid
valproate
has patient
delivery, obstetric
effects of exposure to external cause, nos
mosaic variegated aneuploidy syndrome
Abstracting and Indexing
child, nos
valproate
---
https://www.has-sante.fr/jcms/p_3576148/fr/sam-de-l-ansm-sur-la-carbamazepine-modification-des-conditions-de-prescription-et-de-delivrance-cpd-pour-les-patientes-afin-de-reduire-les-risques-malformatifs-lies-a-l-exposition-in-utero
2025
France
evaluation of the transparency committee
professional practice
congenital abnormalities
prescription, nos
pharmaceutical preparations
operations research
indexing
macrophage activation syndrome
carbamazepine
risk
tool, nos
Exhibition
decision support techniques
meconium aspiration syndrome
patients
uterus, nos
carbamazepine
has patient
mosaic variegated aneuploidy syndrome
delivery, obstetric
developmental anomaly, nos
drug, nos
effects of exposure to external cause, nos
Abstracting and Indexing
---
https://www.has-sante.fr/jcms/p_3576200/fr/iqirvo-elafibranor-cholangite-biliaire-primitive-cbp
2025
false
false
false
France
drug therapy, combination
evaluation of the transparency committee
cholangitis
elafibranor
Primary Biliary Cholangitis
---
https://www.has-sante.fr/jcms/p_3576525/fr/ogsiveo-nirogacestat-tumeurs-desmoides
2025
false
false
false
France
nirogacestat
treatment outcome
insurance, health, reimbursement
Tumor Progression
Refractory Desmoid Fibromatosis
adult
administration, oral
Gamma Secretase Inhibitors
nirogacestat
evaluation of the transparency committee
ogsiveo
Desmoid Tumors
---
https://www.has-sante.fr/jcms/p_3576557/fr/vyloy-zolbetuximab-adenocarcinome-gastrique-et-de-la-jonction-oesogastrique
2025
false
false
false
France
antineoplastic combined chemotherapy protocols
treatment outcome
insurance, health, reimbursement
adult
Fluoropyrimidine
platinum salt, nos
Gastric Adenocarcinoma
stomach neoplasms
Gastroesophageal Junction Adenocarcinoma
esophageal neoplasms
HER2/Neu Negative
CLDN18.2 Positive
infusions, intravenous
zolbetuximab
evaluation of the transparency committee
zolbetuximab
adenocarcinoma
---